source
- Eli Lilly's Mounjaro gets FDA approval to cut heart attack, stroke risk in type 2 diabetesThe U.S. Food and Drug Administration has approved Eli Lilly's Mounjaro for reducing the risk of heart attack, stroke, or cardiovascular death in adults with type 2 diabetes who are at high risk fo…
- BioNTech stops Phase 2 colorectal cancer mRNA vaccine trial after futility findingsBioNTech announced that it is ending its Phase 2 study of a personalized mRNA vaccine for resected colorectal cancer after the trial failed to show the needed benefit. The news sent the company’s s…